Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 454

    1.

    Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.

    Jucker BM, Schaeffer TR, Haimbach RE, McIntosh TS, Chun D, Mayer M, Ohlstein DH, Davis HM, Smith SA, Cobitz AR, Sarkar SK.

    Diabetes. 2002 Jul;51(7):2066-73.PMID: 12086934 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.

    Jucker BM, Schaeffer TR, Haimbach RE, Mayer ME, Ohlstein DH, Smith SA, Cobitz AR, Sarkar SK.

    Metabolism. 2003 Feb;52(2):218-25.PMID: 12601636 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle.

    Jucker BM, Barucci N, Shulman GI.

    Am J Physiol. 1999 Sep;277(3 Pt 1):E505-12.PMID: 10484363 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat.

    Jucker BM, Rennings AJ, Cline GW, Shulman GI.

    J Biol Chem. 1997 Apr 18;272(16):10464-73.PMID: 9099689 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.

    Kim JK, Wi JK, Youn JH.

    Diabetes. 1996 Apr;45(4):446-53.PMID: 8603766 [PubMed - indexed for MEDLINE]Related articles

    7.

    Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.

    Oshida Y, Kako M, Nakai N, Shimomura Y, Li L, Sato J, Ohsawa I, Sato Y.

    Endocr J. 1999 Oct;46(5):723-30.PMID: 10670760 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

    Bergeron R, Previs SF, Cline GW, Perret P, Russell RR 3rd, Young LH, Shulman GI.

    Diabetes. 2001 May;50(5):1076-82.PMID: 11334411 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats.

    Kim JK, Wi JK, Youn JH.

    Diabetes. 1996 May;45(5):651-8.PMID: 8621018 [PubMed - indexed for MEDLINE]Related articles

    10.

    In vivo NMR investigation of intramuscular glucose metabolism in conscious rats.

    Jucker BM, Rennings AJ, Cline GW, Petersen KF, Shulman GI.

    Am J Physiol. 1997 Jul;273(1 Pt 1):E139-48.PMID: 9252490 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.

    Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM.

    Metabolism. 2001 Nov;50(11):1294-300.PMID: 11699047 [PubMed - indexed for MEDLINE]Related articles

    13.

    Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases in vivo insulin sensitivity in conscious adult rats.

    Koopmans SJ, Leighton B, DeFronzo RA.

    Diabetologia. 1998 Jul;41(7):813-20.PMID: 9686923 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.

    Sreenan S, Keck S, Fuller T, Cockburn B, Burant CF.

    Am J Physiol. 1999 Jun;276(6 Pt 1):E1119-29.PMID: 10362626 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Mechanism of troglitazone action in type 2 diabetes.

    Petersen KF, Krssak M, Inzucchi S, Cline GW, Dufour S, Shulman GI.

    Diabetes. 2000 May;49(5):827-31.PMID: 10905493 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans.

    Laurent D, Petersen KF, Russell RR, Cline GW, Shulman GI.

    Am J Physiol. 1998 Jan;274(1 Pt 1):E130-8.PMID: 9458758 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.

    Hawkins M, Barzilai N, Chen W, Angelov I, Hu M, Cohen P, Rossetti L.

    Diabetes. 1996 Dec;45(12):1734-43.PMID: 8922359 [PubMed - indexed for MEDLINE]Related articles

    18.

    Thiazolidinediones influence plasma steroids of male obese Zucker rats.

    Fürnsinn C, Nowotny P, Brunmair B, Gras F, Roden M, Waldhäusl W, Vierhapper H.

    Endocrinology. 2002 Jan;143(1):327.PMID: 11751625 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle.

    Lessard SJ, Lo Giudice SL, Lau W, Reid JJ, Turner N, Febbraio MA, Hawley JA, Watt MJ.

    Endocrinology. 2004 Dec;145(12):5665-70. Epub 2004 Sep 16.PMID: 15375026 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data